Missak Haigentz

6.7k total citations · 1 hit paper
121 papers, 3.8k citations indexed

About

Missak Haigentz is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Missak Haigentz has authored 121 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 50 papers in Otorhinolaryngology and 40 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Missak Haigentz's work include Head and Neck Cancer Studies (49 papers), Lung Cancer Treatments and Mutations (28 papers) and Head and Neck Surgical Oncology (18 papers). Missak Haigentz is often cited by papers focused on Head and Neck Cancer Studies (49 papers), Lung Cancer Treatments and Mutations (28 papers) and Head and Neck Surgical Oncology (18 papers). Missak Haigentz collaborates with scholars based in United States, Netherlands and Italy. Missak Haigentz's co-authors include Alfio Ferlito, Alessandra Rinaldo, Robert P. Takes, Primož Strojan, Carl E. Silver, Juan P. Rodrigo, Patrick J. Bradley, Ashok R. Shaha, Nabil F. Saba and William M. Mendenhall and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Missak Haigentz

117 papers receiving 3.7k citations

Hit Papers

Adenoid cystic carcinoma of the head and neck – An update 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adenoid cystic carcinoma of the head and neck – An update
    2015 342 citations Juan P. Rodrigo, Vincent Vander Poorten et al. Oral Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Missak Haigentz United States 37 1.8k 1.7k 1.6k 903 736 121 3.8k
Mark C. Weissler United States 37 1.4k 0.8× 2.3k 1.3× 1.6k 1.0× 1.0k 1.1× 1.2k 1.6× 148 4.7k
Shiang‐Fu Huang Taiwan 40 1.6k 0.9× 3.0k 1.7× 2.3k 1.4× 918 1.0× 1.0k 1.4× 194 5.1k
Richard Shaw United Kingdom 42 1.2k 0.7× 2.1k 1.2× 2.4k 1.5× 1.0k 1.2× 1.0k 1.4× 160 5.3k
Hung‐Ming Wang Taiwan 41 1.6k 0.9× 2.9k 1.7× 1.9k 1.2× 993 1.1× 870 1.2× 159 4.8k
Anil D′Cruz India 32 1.1k 0.6× 1.9k 1.1× 1.5k 1.0× 1.0k 1.1× 337 0.5× 138 3.3k
Thom R. Loree United States 38 1.1k 0.6× 1.2k 0.7× 2.1k 1.3× 661 0.7× 440 0.6× 85 4.5k
Scott Saxman United States 21 2.5k 1.4× 2.2k 1.3× 2.4k 1.5× 1.5k 1.7× 1.2k 1.7× 41 5.5k
Shanthi Marur United States 21 1.4k 0.8× 2.3k 1.4× 1.3k 0.8× 1.0k 1.1× 1000 1.4× 49 4.2k
Joseph Curry United States 32 1.1k 0.6× 599 0.3× 1.2k 0.8× 636 0.7× 1.1k 1.5× 238 3.6k
David M. Cognetti United States 25 932 0.5× 835 0.5× 860 0.6× 672 0.7× 644 0.9× 167 2.7k

Countries citing papers authored by Missak Haigentz

Since Specialization
Citations

This map shows the geographic impact of Missak Haigentz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Missak Haigentz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Missak Haigentz more than expected).

Fields of papers citing papers by Missak Haigentz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Missak Haigentz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Missak Haigentz. The network helps show where Missak Haigentz may publish in the future.

Co-authorship network of co-authors of Missak Haigentz

This figure shows the co-authorship network connecting the top 25 collaborators of Missak Haigentz. A scholar is included among the top collaborators of Missak Haigentz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Missak Haigentz. Missak Haigentz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Haigentz, Missak, Jeannette Y. Lee, Elizabeth Y. Chiao, et al.. (2023). Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087). Clinical Cancer Research. 29(24). 5038–5046. 3 indexed citations
3.
Aggarwal, Charu, Nabil F. Saba, Alain P. Algazi, et al.. (2022). Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 29(3). 560–570. 26 indexed citations
4.
Haigentz, Missak, Page C. Moore, Timothy P. Cooley, et al.. (2022). Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study. The Oncologist. 27(8). 623–e624. 4 indexed citations
5.
Aggarwal, Charu, Nabil F. Saba, Alain P. Algazi, et al.. (2020). 916MO Safety and efficacy of MEDI0457 plus durvalumab in patients (pts) with human papillomavirus-associated recurrent/metastatic head and neck squamous cell carcinoma (HPV+ R/M HNSCC). Annals of Oncology. 31. S661–S662. 16 indexed citations
6.
7.
Mäkitie, Antti, Alhadi Almangush, Omar Youssef, et al.. (2019). Exhaled breath analysis in the diagnosis of head and neck cancer. Head & Neck. 42(4). 787–793. 15 indexed citations
8.
Siu, Lillian L., Joshua Bauml, Douglas Adkins, et al.. (2019). Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV+NPC).. Journal of Clinical Oncology. 37(15_suppl). TPS6092–TPS6092. 3 indexed citations
9.
Hamoir, Marc, Sandra Schmitz, Carlos Suárez, et al.. (2018). The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma. Cancers. 10(8). 267–267. 88 indexed citations
10.
Li, Tianhong, Bilal Piperdi, William Walsh, et al.. (2016). Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non–small-cell Lung Cancer. Clinical Lung Cancer. 18(1). 60–67. 6 indexed citations
11.
Kaubisch, Andreas, et al.. (2016). Multiple Endocrine and Neoplastic Diseases After Unsuccessful Treatment of Hepatitis C With Interferon and Ribavirin. The American Journal of the Medical Sciences. 354(1). 66–66.
12.
Love, Charito, et al.. (2014). Long-Term Disease Control in a Patient With Recurrent Bone-Only Oligometastatic Nasopharyngeal Carcinoma. Journal of Clinical Oncology. 34(4). e25–e26. 11 indexed citations
13.
Takes, Robert P., Alessandra Rinaldo, Carl E. Silver, et al.. (2012). Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects. Oral Oncology. 48(9). 775–779. 137 indexed citations
14.
Owen, Randall P., Abdissa Negassa, Jonathan J. Beitler, et al.. (2011). Radiofrequency Ablation of Advanced Head and Neck Cancer. Archives of Otolaryngology - Head and Neck Surgery. 137(5). 493–493. 11 indexed citations
15.
Robbins, K. Thomas, Alfio Ferlito, Carl E. Silver, et al.. (2010). Contemporary management of sinonasal cancer. Head & Neck. 33(9). 1352–1365. 51 indexed citations
16.
Takes, Robert P., Alessandra Rinaldo, Carl E. Silver, et al.. (2010). Future of the TNM classification and staging system in head and neck cancer. Head & Neck. 32(12). 1693–1711. 89 indexed citations
17.
Chung, Jong‐Hyuk, et al.. (2008). Lung cancer in HIV infection: A case series. Journal of Clinical Oncology. 26(15_suppl). 19093–19093. 1 indexed citations
18.
Mekhail, Tarek, Scott Gettinger, George R. Blumenschein, et al.. (2007). A phase II trial of VNP40101M in patients with relapsed or refractory small cell lung cancer (SCLC) with or without brain metastases. Journal of Clinical Oncology. 25(18_suppl). 7724–7724. 4 indexed citations
19.
Haigentz, Missak & Román Pérez-Soler. (2003). Chemopreventive Therapeutics: Inhalation Therapies for Lung Cancer and Bronchial Premalignancy. Lung Cancer. 75. 771–780. 2 indexed citations
20.
Haigentz, Missak, Mimi Kim, Joan Sorich, et al.. (2003). Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies. Anti-Cancer Drugs. 14(4). 321–326. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark C. Weissler Breakdown of academic impact, for papers by Shiang‐Fu Huang Breakdown of academic impact, for papers by Richard Shaw Breakdown of academic impact, for papers by Hung‐Ming Wang Breakdown of academic impact, for papers by Anil D′Cruz Breakdown of academic impact, for papers by Thom R. Loree Breakdown of academic impact, for papers by Scott Saxman Breakdown of academic impact, for papers by Shanthi Marur Breakdown of academic impact, for papers by Joseph Curry Breakdown of academic impact, for papers by David M. Cognetti
Rankless by CCL
2026